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A joint meeting between industry, policy
makers, and academic investigators to dis-
cuss the implications for human health of
nasal toxicity and dosimetry of inhaled
xenobiotics was held in Durham, North
Carolina, 20-22 September 1993. The
conference was hosted by the Chemical
Industry Institute ofToxicology (CHT).
The nose is usually the first contact in
the respiratory tract for many airborne
chemicals of environmental and occupa-
tional concern. There is increasing interest
in nasal toxicity and dosimetry of inhaled
chemicals. This interest stems not only
from the basic toxicological issues but also
from the implications of the research for
assessing potential human risks. The broad
goals ofthe meeting were to assess the state
of knowledge concerning nasal toxicity in
humans and animals, to examine issues
encountered in using animal data to assess
human risk, and to identify areas ofresearch
that will improve our ability to make inter-
species comparisons of nasal toxicity and
dosimetry of inhaled chemicals in the
future. Some of the more specific goals of
the meeting were to discuss the toxic
responses observed in the nasal passages and
determine which lesions should be consid-
ered significant. The questions ofseverity of
lesions at different levels and of adaptive
response versus an adverse lesion were also
addressed. The state ofthe art in dosimetry
modeling was presented to toxicologists
with the focus of discussion on what new
data are needed to move modeling to the
next level in understanding and extrapolat-
ing nasal toxicity responses to humans.
A major issue for toxicology studies is
extrapolation of results from the animal
species to humans and from higher expo-
sure concentrations often used in animal
studies to human exposures at concentra-
tions several orders of magnitude lower. It
was obvious from the presentations at this
conference that this complex issue of
extrapolation is even more difficult for the
nasal passages, which differ in structure
and function in rodents from those in
humans. Most animals are obligate nose
breathers, and patterns of breathing are
also different among species. The confer-
ence ended with specific case studies used
for setting human exposure limits. The
cases were specifically chosen from differ-
ent agencies to highlight the differences
and similarities used by policy makers deal-
ing with varying exposure populations (i.e.,
occupational exposures versus environmen-
tal exposures). The focus was on what
important issues have surfaced in establish-
ing exposure limits thus far.
With increasing knowledge and scien-
tific complexity and with decreasing
research dollars, it is crucial to work
together to make sound scientific decisions
to protect public health, as well as to make
better and safer new products and tech-
nologies to continue to improve our lives.
Extrapolation is estimating what is not
readily observed from that which can be
directly observed. While the primary con-
cern is overt disease, with improved scien-
tific technology, much smaller alterations
can now be detected in test animals, but
when do these alterations represent an
adverse effect? Understanding the mecha-
nism will help to separate an adverse effect
from an adaptive response. In the future,
with limited resources, policy makers will
need to work closer with industry and aca-
demic toxicologists to determine what data
are needed for sound policy decisions.
The mathematical approach has been
used for modeling nasal cavity exposure.
The advantages ofthe modeling came from
simulating complex behavior of the flow of
the gases through the nasal passage and
allowing better visualization of complex
processes of where the chemical or toxic
metabolite is deposited. Mathematical mod-
eling can help provide a basis for extrapolat-
ing from short- to long-term exposure, from
high to low concentrations, and between
different species with widely varying nasal
structures and air flow patterns. The avail-
ability ofsupporting toxicology data is cru-
cial in the validation and further develop-
ment ofany mathematical model.
The complexity of the nose continued
to be highlighted. For example, variations
in the thickness of the mucous layer, the
pH of the layer, plus mucous and airflow
patterns result in different patterns oftoxic-
ity. There are multiple models for estimat-
ing tissue buildup of toxic materials, and
each model has disadvantages and advan-
tages depending on the question asked. The
model is used to visualize "hot spots" in the
nose where toxicity may be expected. By
using plastic models and fluid flow to simu-
late air flow in the nasal passages, it was
interesting to note that rodents and pri-
mates have different flow patterns, but
computer models correlated well with the
flow ofcolored dyes in aqueous models. An
enlarged physical model (20 times larger
than actual size) and a finite element com-
puter model of the human nose was con-
structed based on CAT scans of patients.
This work compares well with the model-
ing efforts in both rodent and nonhuman
primate noses. For this field to progress,
toxicology data are needed to refine the
models. Further study ofthe boundary con-
ditions at the air/mucous interface and the
mucous/tissue/blood interface in the nasal
cavity is needed.
Nasal uptake ofvapor was measured in
a variety oflaboratory animal species. The
data revealed that uptake of acetone, a
nonreactive, nonmetabolized vapor, was
more efficient in the rat (Sprague-Dawley,
F344) or mouse (B6C3F1) nose than in
that of the hamster or guinea pig. These
studies suggest that nasal tissue perfusion
rate, which may vary between species,
influences uptake of nonreactive, nonme-
tabolized vapors. Uptake of directly reac-
tive and/or metabolized vapors displayed
differing and variable species or strain dif-
ferences, suggesting that species differences
in metabolic potential may be important
and should be considered when extrapolat-
ing animal nasal toxicity data to humans.
Based on l 0 isotope studies, about
14% of inhaled ozone is retained in the
rat's head. 180 uptake in both humans and
rats correlates with ozone toxicity. Thus,
this model accurately predicts ozone toxic-
ity across species and model systems. The
toxic responses in animals and risk assess-
ment of ethyl acrylate, a polymer used in
latex paint and in a wide variety of other
products, was discussed. Nasal toxicity is
an important toxic effect ofethyl acrylate.
Air flow, blood flow in the nasal cavity,
and glutathione levels in the different nasal
tissues are important in determining the
location and severity of nasal toxicity in
animal models. Formaldehyde dosimetry
predictions for site-specific toxicity were
presented, which correlated well with the
occurrence of neoplasms in the rat nasal
passage. DNA protein cross-linking was
shown to be a good biological marker of
potential toxicity and eventual tumor
response for this chemical. Cell prolifera-
tion was also increased in the areas where
toxicity was found. The toxicity, cross-
linking, and cell proliferation were all
found at 6 and 15 ppm, but not at lower
concentrations, and this nonlinearity has
implications for risk assessment at low
formaldehyde concentrations.
The second day of the conference
focused on the nasal lesions found in
humans and animals. The distribution of
nasal lesion by the type of epithelium
involved was discussed. For most species
there are four distinct epithelial cell types:
1) squamous epithelium that lines the
Address correspondence to G.A. Boorman,
NIEHS, PO Box 12233, Research Triangle Park,
NC 27709.
Environmental Health Perspectives 3181--=I - ----M --- ME
99 -
nasal vestibule, 2) transitional (cuboidal,
nonciliated) epithelium that occurs
between the squamous and respiratory
epithelium, especially on the lateral wall, 3)
respiratory epithelium that covers the
majority ofthe nasal passage, and 4) olfac-
tory epithelium that occurs dorsally and
caudally over the ethmoid turbinate. Based
on the airflow patterns, the primary loca-
tion for lesions of the respiratory epitheli-
um is the mid-ventral septum and the mid-
dle turbinate, which correlates well with
predictions by computer models. It was
stressed that it is crucial for the toxicologi-
cal pathologist to use care in recording
lesions. The diagnosis "hyperplasia, nasal
cavity" is not helpful for the policy maker
and is meaningless for scientists trying to
advance modeling systems to predict nasal
toxicity. Thus, lesions need to be recorded
carefully by site, severity, level ofnasal cav-
ity, type ofepithelium involved, etc.
The different epithelial types in the
nasal airways were discussed. Regional
responses to inhaled toxicants could be
quite different. For example, short-term
ozone exposure induces cell replication in
transitional epithelium with little prolifera-
tive response in other nasal epithelia. The
acute effects (2 weeks) ofozone at low con-
centrations (0.12 ppm) were restricted to
the anterior portion of the nasal passages,
but chronic exposures (20 months, 5 days/
week, 6 hr/day) caused alterations in both
anterior and posterior aspects of the nasal
airways. In rats at 0.12 ppm, there was lit-
tle or no effect, while at 0.5 and 1 ppm
clear effects could be found in F344/N rats
after 20 of months exposure. Ozone
induces an increase in the mucous goblet
cells in the transitional epithelium in both
rats and nonhuman primates. This raises
the question ofwhether this is an adaptive
response or whether it should be consid-
ered an adverse response to ozone expo-
sure. These structural alterations have been
correlated with functional alterations (i.e.,
mucostasis).
Toxicity to the olfactory mucosa was
the next topic. This epithelium has meta-
bolic capacities and is susceptible to toxici-
ty, especially from compounds that are
metabolized to a toxic metabolite. Some
chemicals given systemically can cause
olfactory mucosa toxicity. For example,
phenacetin given orally to rats will result in
microcysts in the olfactory epithelium.
Methyl bromide is another compound that
given orally can impair the olfactory senses.
Dibasic esters caused toxicity ofthe susten-
tacular cell of the olfactory epithelium.
Female rats were more sensitive to this
effect than males.
Chemical toxicity in the accessory nasal
structures was also presented. The nasal
passages contain numerous glands and
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structures that are often overlooked in tox-
icity studies. The glands of the nasal pas-
sage include Bowman's glands, Steno's
glands, septal glands, and turbinate glands.
The vomeronasal organ is important in the
sense ofsmell and is related to sexual activ-
ity. There are numerous examples oftoxic-
ity; in some cases, toxicity may be more
severe in the glands than in other tissues.
For example, with exposure to the tobacco-
specific nitrosoamine 4-(N-methyl-N-
nitrosamino)-1-(3-pyridyl)- 1-butanone,
there is severe toxicity in Steno's glands.
The olfactory epithelium was described
as a "window to the brain" and noted that
neurological changes for Alzheimer
patients can be found in nasal biopsies of
the olfactory epithelium. This was discov-
ered subsequent to the clinical observation
that Alzheimer patients quickly lose their
sense ofsmell.
An overview of nasal lesions found in
clinical practice showed that the diversity
of lesions and different types of exposure
patterns are broad. Patients are often
exposed at home and at the workplace.
Some occupations, such as furniture mak-
ing or wood working, are associated with
an increased incidence of nasal tumors in
the UK and other countries.
The third day dealt with implications
ofchemically induced nasal toxicity for set-
ting exposure limit values. Both toxicolo-
gists and scientists at government agencies
recognize that there are ranges of human
responses, that there are complex dose-
response relationships, that lesions may
vary in their severity, persistence, and
homology, and that some lesions found in
animal studies may not represent adverse
responses in humans. Policy makers need
to play a more active role in deciding the
type and level of data that are needed for
sound decisions. It was suggested that poli-
cy makers help decide what improvements
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in our knowledge base during the next
decade would provide a sounder scientific
basis for regulatory decisions.
Exposure limit regulations include a
number ofuncertainty factors in the calcu-
lations. The number ofuncertainty factors
may be reduced ifthere are more and bet-
ter scientific studies; uncertainty factors
that remain will be better defined. Human
data are preferred for setting limits but are
often not available. There were some ques-
tions about the possible redundancy ofdif-
ferent regulatory agencies working on set-
ting limits for the same chemical with dif-
ferent criteria and uncertainty factors.
Some differences are related to the particu-
lar application, i.e., higher but shorter
workplace exposure as opposed to lower
environmental exposures that may extend
for a life-time.
There is increasing concern about
chemically sensitive populations and expo-
sures to multiple chemicals when setting
exposure limits. Some exposures to multi-
ple chemicals arevoluntary (e.g., smoking).
The endpoints from these exposures vary
widely in incidence and severity; nasal dis-
charge may occur at a high incidence but is
not severe, whereas nasal cancer is a rare
(but important) event.
The approaches that various agencies
use in assessing human health risks and
establishing exposure limits were discussed.
Two examples ofinhalation reference con-
centrations that have nasal endpoints were
presented.
In summary, modelers and toxicolo-
gists need to be in touch with the policy
makers to be sure that their data and
research direction will be helpful for mak-
ing regulatory decisions. Policy makers are
now more responsive to the scientific com-
munity and have access to better science
upon which to base policy decisions.
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